Atlas Trials

Advanced Solid Cancers

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Advanced Solid Cancers

RecordFirmDate
An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid Cancers (NCT03956680)Bristol-Myers Squibb2019-03-26
Study of SRF231 in Patients With Advanced Solid and Hematologic Cancers (NCT03512340)Surface Oncology2018-03-13
A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors (NCT02792465)University Health Network, Toronto2016-11-11
AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Participants With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy (NCT02694822)Agenus Inc.2016-04-01
Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer (NCT01019941)Chong Kun Dang Pharmaceutical2009-08-01
A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors (NCT00886782)Bristol-Myers Squibb2009-05-31
A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers (NCT00337376)Yale University2006-02-01

Track Advanced Solid Cancers automatically

Every clearance here is in the API, with alerts when new ones post.